Biomarker Study in Participants With Migraine

Summary

This is a study of participants with a diagnosis of migraine who completed another clinical trial NCT02163993. The participants received either LY2951742 or placebo. This study NCT02766517 will evaluate how certain biomarkers may be related to the participant's response in study NCT02163993. The study will last about five days.

Timeline

Start

2016-09-28

Primary completion

2017-01-01

Completion

2017-01-01

Drugs

Indications